UA99645C2 - Гель, имеющий противовоспалительное и противоаллергическое действие - Google Patents
Гель, имеющий противовоспалительное и противоаллергическое действиеInfo
- Publication number
- UA99645C2 UA99645C2 UAA201011783A UAA201011783A UA99645C2 UA 99645 C2 UA99645 C2 UA 99645C2 UA A201011783 A UAA201011783 A UA A201011783A UA A201011783 A UAA201011783 A UA A201011783A UA 99645 C2 UA99645 C2 UA 99645C2
- Authority
- UA
- Ukraine
- Prior art keywords
- inflammatory
- gel
- antiallergic
- antiallergic gel
- dimethyldihydropirimidone
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0014—Skin, i.e. galenical aspects of topical compositions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/13—Amines
- A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
- A61K31/513—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim having oxo groups directly attached to the heterocyclic ring, e.g. cytosine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
- A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
- A61K47/32—Macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. carbomers, poly(meth)acrylates, or polyvinyl pyrrolidone
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/02—Nasal agents, e.g. decongestants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/04—Antipruritics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
- A61P27/14—Decongestants or antiallergics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/08—Antiallergic agents
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Epidemiology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Dermatology (AREA)
- Pulmonology (AREA)
- Otolaryngology (AREA)
- Pain & Pain Management (AREA)
- Rheumatology (AREA)
- Ophthalmology & Optometry (AREA)
- Oncology (AREA)
- Communicable Diseases (AREA)
- Inorganic Chemistry (AREA)
- Immunology (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Abstract
Изобретение относится к области медицины и касается геля для внешнего применения, имеющего противовоспалительное и противоаллергическое действие, включающего в качестве активного вещества Ν-(β-оксиэтил)-4,6-диметилдигидропиримидон-2 (ксимедон), в качестве антигистаминного препарата - дифенгидрамин или клемастин, или цетиризин и гелевую основу, содержащую в качестве загустителя карбопол, а также полиэиленоксид с молекулярной массой 400-6000 Да, глицерин в количестве не больше 20 %, спирт этиловый в количестве не больше 41 % и воду очищенную.
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
RU2008108006/15A RU2370265C1 (ru) | 2008-03-04 | 2008-03-04 | Гель, обладающий противовоспалительным и противоаллергическим действием |
Publications (1)
Publication Number | Publication Date |
---|---|
UA99645C2 true UA99645C2 (ru) | 2012-09-10 |
Family
ID=41065445
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
UAA201011783A UA99645C2 (ru) | 2008-03-04 | 2009-03-03 | Гель, имеющий противовоспалительное и противоаллергическое действие |
Country Status (5)
Country | Link |
---|---|
EA (1) | EA017660B1 (ru) |
GE (1) | GEP20125719B (ru) |
RU (1) | RU2370265C1 (ru) |
UA (1) | UA99645C2 (ru) |
WO (1) | WO2009113910A1 (ru) |
Families Citing this family (11)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EA019846B1 (ru) | 2008-10-20 | 2014-06-30 | Юнилевер Нв | Противомикробная композиция, содержащая тимол и терпинеол, и ее применение |
AU2010297406B2 (en) | 2009-09-24 | 2013-10-17 | Unilever Plc | Disinfecting agent comprising eugenol, terpineol and thymol |
EA201201632A1 (ru) * | 2010-05-31 | 2013-04-30 | Юнилевер Н.В. | Композиция для ухода за кожей |
EA022986B1 (ru) | 2010-12-07 | 2016-04-29 | Юнилевер Нв | Композиция для ухода за полостью рта |
RU2450807C1 (ru) * | 2011-05-11 | 2012-05-20 | Общество с ограниченной ответственностью фирма "Вита" | Стабилизированный фармацевтический состав с противогрибковым действием |
BR112014009479B8 (pt) | 2011-11-03 | 2019-01-29 | Unilever Nv | composição líquida de limpeza pessoal e método de desinfecção da superfície externa |
RU2543326C2 (ru) * | 2012-08-21 | 2015-02-27 | Открытое акционерное общество "Химико-фармацевтический комбинат "АКРИХИН" (ОАО "АКРИХИН") | Фармацевтическая композиция для лечения зуда кожи |
US9198898B2 (en) | 2013-06-24 | 2015-12-01 | Tigercat Pharma, Inc. | Use of NK-1 receptor antagonists in pruritus |
US8906951B1 (en) | 2013-06-24 | 2014-12-09 | Tigercat Pharma, Inc. | Use of NK-1 receptor antagonists in pruritus |
JP2016523260A (ja) * | 2013-06-24 | 2016-08-08 | タイガーキャット ファーマ インコーポレイテッド | そう痒におけるnk−1受容体アンタゴニストのセルロピタントの使用 |
RU2614961C1 (ru) * | 2015-12-31 | 2017-03-31 | Виктория Александровна Чумакова | Способ изготовления фармацевтической композиции с фексофенадином, обладающей противоаллергическим и противовоспалительным действием |
Family Cites Families (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
RU2280438C2 (ru) * | 2004-01-13 | 2006-07-27 | Государственное Предприятие "Государственный Научный Центр Лекарственных Средств" (Гнцлс) | Средство "форидон-гель" для лечения и профилактики сердечно-сосудистых заболеваний |
RU2317811C1 (ru) * | 2006-06-19 | 2008-02-27 | Лев Давидович Раснецов | Фармацевтическая композиция для лечения ожогов (варианты) и способ ее получения (варианты) |
-
2008
- 2008-03-04 RU RU2008108006/15A patent/RU2370265C1/ru active
-
2009
- 2009-03-03 WO PCT/RU2009/000103 patent/WO2009113910A1/ru active Application Filing
- 2009-03-03 UA UAA201011783A patent/UA99645C2/ru unknown
- 2009-03-03 EA EA201001324A patent/EA017660B1/ru not_active IP Right Cessation
- 2009-03-03 GE GEAP200911959A patent/GEP20125719B/en unknown
Also Published As
Publication number | Publication date |
---|---|
RU2370265C1 (ru) | 2009-10-20 |
WO2009113910A1 (ru) | 2009-09-17 |
EA201001324A1 (ru) | 2011-02-28 |
GEP20125719B (en) | 2012-12-25 |
EA017660B1 (ru) | 2013-02-28 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
UA99645C2 (ru) | Гель, имеющий противовоспалительное и противоаллергическое действие | |
AR062000A1 (es) | Formulaciones de modificador de respuesta inmune | |
WO2007098128A3 (en) | Phenylephrine-containing liquid formulations | |
ITFI20050042A1 (it) | N-idrossiammidi -sostituiti con gruppi triciclici come inibitori dell'istone deacelitasi,loro preparazione ed impiego in formulazioni farmaceutiche | |
TW200716628A (en) | Novel compounds | |
WO2007093450A3 (en) | Deuterated catecholamine derivatives and medicaments comprising said compounds | |
MY148496A (en) | Dpp iv inhibitor formulations | |
CL2008001114A1 (es) | Compuestos derivados de bencimidazol; composicion farmaceutica; y uso en el tratamiento de enfermedades tales como vejiga sobreactiva, dolor, obesidad, convulsiones, entre otras. | |
PE20140960A1 (es) | Formulaciones que comprenden un inhibidor de dpp4 | |
MY140514A (en) | Triazolopyridine derivatives as inhibitors of lipases and phospholipases | |
AR060019A1 (es) | Composicion farmaceutica, producto y metodo de tratamiento para un trastorno cognitivo y usos de un inhibidor de acetilcolinesterasa y un antagonista de 5- ht6 en la fabricacion de un medicamento para el tratamiento de un trastorno cognitivo | |
TW200716204A (en) | Pharmaceutical composition | |
WO2005075471A3 (en) | Thiazol-compounds as 11-beta-hydroxysteroid dehydrogenase type 1 inhibitors | |
UA110013C2 (uk) | Застосування композиції для лікування шарко-марі-тута і пов'язаних з нею розладів | |
TW200730513A (en) | Carbamoylbenzotriazole derivatives as inhibitors of lipases and phospholipases | |
MX2009007784A (es) | Composiciones de tiacumicinas estables. | |
BRPI1009392A2 (pt) | "formulação farmacêutica, e, uso de uma quantidade farmaceuticamente eficaz de uma formulação farmacêutica." | |
PL1608346T3 (pl) | Kompozycje dostarczające lek zawierające estry alfa-hydroksykwasów i sposób ich zastosowania | |
AR078283A1 (es) | Formulaciones de suspension oral de dibenzazepina carboxamidas | |
UA96794C2 (ru) | Глюкокортикоиды, способ их применения, способ лечения и фармацевтическая композиция на их основе | |
MX2012001853A (es) | Composicion farmaceutica para aliviar el dolor. | |
ATE531703T1 (de) | Benzochromenderivate | |
SG162766A1 (en) | Benzooxazole-2-on derivatives as lipase and phospholipase inhibitors | |
MY142792A (en) | Azolopyridin-2-one derivatives as inhibitors of lipases and phospholipases | |
MY146803A (en) | Benzothiazol-2-on derivatives as lipase and phospholipase inhibitors |